No Image Provided

Sensible Biotechnologies

VC Funding

Pre-Seed Angel-backed

Healthcare & Biotech Published 6 April 2023

Summary

In a significant market movement during April 2023, Sensible Biotechnologies was the subject of a vc funding. The transaction achieved a gross valuation of £3,366,734. Leading the round was Zaka, Amino Collective, Recode Health Ventures, Jason C. Foster, Civilization Ventures, BlueYard Capital, Y Combinator, Florian Schuster.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

Zaka

Lead Investor / Acquirer

Amino Collective

Lead Investor / Acquirer

Recode Health Ventures

Lead Investor / Acquirer

Jason C. Foster

Lead Investor / Acquirer

Civilization Ventures

Lead Investor / Acquirer

BlueYard Capital

Lead Investor / Acquirer

Y Combinator

Lead Investor / Acquirer

Florian Schuster

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Pre-Seed prioritised

VC Funding

Scan.com

£67,220,000

Sept 2026

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

VC Funding

NuVision Biotherapies

£4,800,000

Mar 2026

VC Funding

Evaro

£18,000,000

Jan 2026

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.